We are live on ! Find out more
PBE icon

Invesco Biotechnology & Genome ETF
PBE

87 hedge funds and large institutions have $165M invested in Invesco Biotechnology & Genome ETF in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

28% more capital invested

Capital invested by funds: $129M → $165M (+$36M)

6% more funds holding

Funds holding: 82 → 87 (+5)

2.07% more ownership

Funds ownership: 28.69% → 30.76% (+2.1%)

9% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 22

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
87
Holders Change
+5
Holders Change %
+6.1%
% of All Funds
2.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
24
Reduced
22
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
QA
Quantitative Advantage
Minnesota
+$5.94M
2
Bank of America
Bank of America
North Carolina
+$4.53M
3
Jane Street
Jane Street
New York
+$2.41M
4
UBS Group
UBS Group
Switzerland
+$2.07M
5
Citadel Advisors
Citadel Advisors
Florida
+$1.61M

Top Sellers

Rank Fund Capital Flow
1
CLOS
Compagnie Lombard Odier SCmA
Switzerland
-$1.25M
2
Wells Fargo
Wells Fargo
California
-$649K
3
NPC
National Planning Corporation
California
-$335K
4
Morgan Stanley
Morgan Stanley
New York
-$320K
5
SAM
SignalPoint Asset Management
Missouri
-$227K
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
26
US Bancorp
Minnesota
$1.34M -$10.8K -200 -0.8%
VF
27
Virtu Financial
New York
$1.29M +$1.26M +23,384 New
WBG
28
Wharton Business Group
Pennsylvania
$1.24M -$31.4K -580 -3%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$1.18M +$649K +12,003 +128%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$1.14M +$1.12M +20,745 New
OPCM
31
Osborne Partners Capital Management
California
$991K – – –
CWM
32
Concert Wealth Management
California
$929K – – –
Envestnet Asset Management
33
Envestnet Asset Management
Illinois
$868K +$22.6K +419 +3%
OIA
34
Optimum Investment Advisors
Illinois
$843K +$163K +3,015 +25%
Ameriprise
35
Ameriprise
Minnesota
$795K +$520K +9,626 +201%
MAA
36
Managed Account Advisors
New Jersey
$793K +$133K +2,463 +21%
WB
37
Webster Bank
Connecticut
$746K -$17.6K -325 -2%
Millennium Management
38
Millennium Management
New York
$651K -$3.78K -70 -0.6%
BPC
39
Banque Pictet & Cie
Switzerland
$650K – – –
Janney Montgomery Scott
40
Janney Montgomery Scott
Pennsylvania
$622K +$17.5K +323 +3%
Citigroup
41
Citigroup
New York
$517K +$12.8K +236 +3%
CFS
42
Commonwealth Financial Services
West Virginia
$509K – – –
Neuberger Berman Group
43
Neuberger Berman Group
New York
$418K – – –
SWA
44
SFMG Wealth Advisors
Texas
$403K +$395K +7,314 New
B
45
Baird
Wisconsin
$399K -$84.2K -1,558 -18%
CIC
46
Carnegie Investment Counsel
Ohio
$398K – – –
LTFS
47
Ladenburg Thalmann Financial Services
Florida
$386K -$18.8K -348 -5%
JIC
48
Joel Isaacson & Co
New York
$380K – – –
OC
49
Oppenheimer & Co
New York
$337K -$101K -1,863 -23%
PJSIMP
50
P.J. Schmidt Investment Management (PJS)
Wisconsin
$330K -$13.5K -250 -4%
1
2
3 4

PBE Hedge Fund Activity: Q1 2015 in Review

87 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Invesco Biotechnology & Genome ETF (PBE) for Q1 2015, worth a combined $165M — up 28% from $129M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new PBE positions and 8 closed out — a net gain of 6 holders — while 24 added to existing stakes and 22 trimmed.

The largest buyer was Quantitative Advantage, opening a new position worth an estimated $5.94M. The largest seller was Compagnie Lombard Odier SCmA, exiting entirely with an estimated $1.25M sold.

  • 87 institutional investors held Invesco Biotechnology & Genome ETF (PBE) as of Q1 2015, up from 82 in Q4 2014.
  • Funds reported $165M of Invesco Biotechnology & Genome ETF stock for Q1 2015, up 28% quarter-over-quarter.
  • 14 funds opened new Invesco Biotechnology & Genome ETF positions in Q1 2015 and 8 closed out, a net change of +6 holders.
  • The largest Invesco Biotechnology & Genome ETF buyer in Q1 2015 was Quantitative Advantage, an estimated $5.94M added.
  • The largest Invesco Biotechnology & Genome ETF seller in Q1 2015 was Compagnie Lombard Odier SCmA, an estimated $1.25M sold.

Based on aggregated 13F filings for Q1 2015.